Menu

Posaconazole DR

Strength: 100mg Count: 60

NDC

42291-919-60

Class

Rx

Brand Name

Noxafil

Imprint Code

AC71

Color(s)

Yellow

Shape

Oval (oblong)

Score

No Score

Case Count

NA

Inactive Ingredients

colloidal silicon dioxide, croscarmellose sodium, ferrosoferric oxide black, hydroxypropylcellulose, hypromellose acetate succinate, iron oxide yellow, Macrogol/PEG 3350, magnesium stearate, microcrystalline cellulose, polyvinyl alcohol partially hydrolyzed, talc and titanium dioxide

Indications and Usage

Posaconazole delayed-release tablets are indicated for the prophylaxis of invasive Aspergillus and Candida infections in patients who are at high risk of developing these infections due to being severely immunocompromised, such as hematopoietic stem cell transplant (HSCT) recipients with graft-versus-host disease (GVHD) or those with hematologic malignancies with prolonged neutropenia from chemotherapy